Diabetes decisions — 2025

The Board denied service connection for the cause of the Veteran's death, finding that his death was not attributable to service.

The Veteran's claims for diabetes, bladder cancer, hypertension, and bronchitis have all been denied as there is no persuasive evidence of a current disability or a nexus to service.,Service connection was not granted because the medical records do not support a finding that any of these conditions began during or shortly after service.

The Board has granted service connection for diabetes mellitus, type II on a presumptive basis due to exposure to herbicide agents during active service in Vietnam. The Veteran's current diagnosis of diabetes mellitus, type II is considered as the result of his qualifying service in Vietnam.

The veteran's service connection claims for diabetes mellitus, coronary artery disease, pseudophakia, and bilateral lower extremity peripheral neuropathy were granted based on presumed exposure to herbicide agents during service at Fort McClellan.

The veteran's claims for service connection for several conditions, including low back disability and diabetes mellitus, type II, were granted. The claim for rheumatic fever was remanded.

The Board remanded the veteran's claims for service connection of several conditions, including type II diabetes mellitus and sleep apnea, to obtain medical opinions on whether these conditions are secondary to service-connected disabilities.

The Board denied service connection for diabetes mellitus, stating that the evidence does not show a relationship between the veteran's diabetes and their military service or service-connected disabilities.

The Board remanded the claim for service connection for diabetes mellitus type II to obtain a medical opinion on the nexus between the Veteran's toxic exposure risk and his claimed disability.

The veteran's claim for service connection for diabetes mellitus, type 2, as secondary to post gastrectomy syndrome was granted. The claim for hypertension was remanded for further evaluation.

The appeal for service connection of diabetes secondary to insomnia and/or tinnitus is remanded. The Board needs a new medical opinion on whether the diabetes was caused or aggravated by these conditions.

The veteran's appeal for a higher disability rating and an earlier effective date for diabetes mellitus, type II was dismissed because the veteran requested to withdraw the appeal.

The Board granted service connection for diabetes mellitus, type II; ischemic heart disease; and peripheral neuropathy in all four extremities.

The Board denied service connection for ischemic heart disease, hypertension, and diabetes mellitus type II because the evidence did not show a link to military service or herbicide exposure.

The Veteran's claims for service connection of coronary artery disease, diabetes mellitus type II, and hypertension due to herbicide agent exposure are remanded. The Board will correct duty-to-assist errors before deciding the remaining claims on appeal.

The Board remanded the veteran's claims for service connection of several conditions due to inadequate VA opinions. The veteran will receive new medical examinations.

The Board remanded the claim for service connection of diabetes mellitus, type II. The Veteran's exposure to jet fuel during his military service is being considered as a potential cause.

The veteran's claim for service connection for unspecified anxiety disorder was granted. All other claims were denied.

The Veteran's service-connected disabilities require regular aid and attendance, so he is granted special monthly compensation (SMC).

The veteran's PTSD rating was increased to 70% from December 7, 2009 to April 29, 2021. The effective date for DEA eligibility was granted as of January 28, 2021. However, the request for an earlier effective date for SMC and a higher level of SMC were denied.

The veteran's appeal resulted in a mixed decision. Some ratings were granted, such as a 30 percent rating for anemia secondary to diabetes mellitus and increased ratings for diabetic neuropathy. However, other claims, including higher ratings for diabetes mellitus and earlier effective dates for service connection, were denied.